BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15755988)

  • 1. AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers.
    Penning TM
    Clin Cancer Res; 2005 Mar; 11(5):1687-90. PubMed ID: 15755988
    [No Abstract]   [Full Text] [Related]  

  • 2. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas.
    Fukumoto S; Yamauchi N; Moriguchi H; Hippo Y; Watanabe A; Shibahara J; Taniguchi H; Ishikawa S; Ito H; Yamamoto S; Iwanari H; Hironaka M; Ishikawa Y; Niki T; Sohara Y; Kodama T; Nishimura M; Fukayama M; Dosaka-Akita H; Aburatani H
    Clin Cancer Res; 2005 Mar; 11(5):1776-85. PubMed ID: 15755999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer.
    Kang MW; Lee ES; Yoon SY; Jo J; Lee J; Kim HK; Choi YS; Kim K; Shim YM; Kim J; Kim H
    J Int Med Res; 2011; 39(1):78-85. PubMed ID: 21672310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKR1B10 in usual interstitial pneumonia: expression in squamous metaplasia in association with smoking and lung cancer.
    Li CP; Goto A; Watanabe A; Murata K; Ota S; Niki T; Aburatani H; Fukayama M
    Pathol Res Pract; 2008; 204(5):295-304. PubMed ID: 18358633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormal expression of genes that regulate retinoid metabolism and signaling in non-small-cell lung cancer].
    Kuznetsova ES; Zinovieva OL; Oparina NY; Prokofjeva MM; Spirin PV; Favorskaya IA; Zborovskaya IB; Lisitsyn NA; Prassolov VS; Mashkova TD
    Mol Biol (Mosk); 2016; 50(2):255-65. PubMed ID: 27239845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.
    Okamoto T; Suzuki Y; Fujishita T; Kitahara H; Shimamatsu S; Kohno M; Morodomi Y; Kawano D; Maehara Y
    Lung Cancer; 2014 Aug; 85(2):125-30. PubMed ID: 24976334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10.
    Matsunaga T; Morikawa Y; Haga M; Endo S; Soda M; Yamamura K; El-Kabbani O; Tajima K; Ikari A; Hara A
    Toxicol Appl Pharmacol; 2014 Jul; 278(2):180-9. PubMed ID: 24813866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker.
    Ma J; Luo DX; Huang C; Shen Y; Bu Y; Markwell S; Gao J; Liu J; Zu X; Cao Z; Gao Z; Lu F; Liao DF; Cao D
    Int J Cancer; 2012 Sep; 131(6):E862-71. PubMed ID: 22539036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems biology analysis of publicly available transcriptomic data reveals a critical link between AKR1B10 gene expression, smoking and occurrence of lung cancer.
    Cubillos-Angulo JM; Fukutani ER; Cruz LAB; Arriaga MB; Lima JV; Andrade BB; Queiroz ATL; Fukutani KF
    PLoS One; 2020; 15(2):e0222552. PubMed ID: 32097409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patients.
    Szymanowska-Narloch A; Jassem E; Skrzypski M; Muley T; Meister M; Dienemann H; Taron M; Rosell R; Rzepko R; Jarząb M; Marjański T; Pawłowski R; Rzyman W; Jassem J
    Adv Med Sci; 2013; 58(2):196-206. PubMed ID: 24451080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transcription TIMP3, DAPk1 and AKR1B10 genes in squamous cell lung cancer].
    Mashkova TD; Oparina NIu; Zinov'eva OL; Kropotova ES; Dubovaia VI; Poltaraus AB; Fridman MV; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Laktionov KK; Kasymova OT; Zborovskaia IB; Sverdlov ED; Kiselev LL
    Mol Biol (Mosk); 2006; 40(6):1047-54. PubMed ID: 17209433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should mutational analyses of tumor samples bypass histopathology?
    Tsao MS
    J Thorac Oncol; 2007 May; 2(5):375-6. PubMed ID: 17473650
    [No Abstract]   [Full Text] [Related]  

  • 14. Postoperative dynamic changes in the concentration of CK19-2G2 in lung cancer patients and the clinical value of this marker.
    Gao J; Lv F; Wang J; Wu Z; Li J; Yan C; Qi J
    Tumour Biol; 2015 Nov; 36(11):8295-9. PubMed ID: 26002573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).
    Subramanian J; Velcheti V; Gao F; Govindan R
    J Thorac Oncol; 2007 Sep; 2(9):827-30. PubMed ID: 17805060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of smoking status in operated non-small cell lung cancer.
    Sardari Nia P; Weyler J; Colpaert C; Vermeulen P; Van Marck E; Van Schil P
    Lung Cancer; 2005 Mar; 47(3):351-9. PubMed ID: 15713518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting success in cancer prevention trials.
    Vourlekis JS; Szabo E
    J Natl Cancer Inst; 2003 Feb; 95(3):178-9. PubMed ID: 12569132
    [No Abstract]   [Full Text] [Related]  

  • 18. Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome.
    Wang CI; Wang CL; Wang CW; Chen CD; Wu CC; Liang Y; Tsai YH; Chang YS; Yu JS; Yu CJ
    Int J Cancer; 2011 May; 128(10):2364-72. PubMed ID: 20658535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking status and adenocarcinoma histology may explain an improved survival in the female non-small cell lung cancer patients.
    Altundag K; Altundag O; Morandi P; Gunduz M
    Lung Cancer; 2005 Jul; 49(1):137; author reply 139. PubMed ID: 15949603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.